Sex Chromosome Aberrations
Welcome,         Profile    Billing    Logout  
 0 Companies   0 Products   0 Products   0 Mechanisms of Action   0 Trials   12 News 
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  LUVIA: The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism (clinicaltrials.gov) -  Dec 28, 2018   
    P=N/A,  N=10, Completed, 
    Recruiting --> Completed | N=28 --> 10 | Trial completion date: Dec 2018 --> Apr 2018 | Trial primary completion date: Dec 2018 --> Apr 2018
  • ||||||||||  Trial completion, Enrollment change:  X-chromosome Inactivation, Epigenetics and the Transcriptome (clinicaltrials.gov) -  May 24, 2016   
    P=N/A,  N=110, Completed, 
    Trial primary completion date: Sep 2017 --> Dec 2018 Active, not recruiting --> Completed | N=395 --> 110
  • ||||||||||  Enrollment closed, Trial primary completion date:  X-chromosome Inactivation, Epigenetics and the Transcriptome (clinicaltrials.gov) -  Jun 29, 2015   
    P=N/A,  N=395, Active, not recruiting, 
    Active, not recruiting --> Completed | N=395 --> 110 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Oct 2015